Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07515872 · ClinicalTrials.gov registry record · Phase 2
Long Duration High Frequency Ultrasound for the Treatment of Osteoarthritis
A Phase 2 study, sponsored by ZetrOZ.
- Not yet
- Registry status
- Phase 2
- Development phase
- 240
- Enrollment target
NCT07515872: Clinical Trial Phase 2 study, sponsored by ZetrOZ.
NCT07515872 is a Phase 2 study that has not yet begun recruiting, run by ZetrOZ. The registered enrollment target is 240 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (80% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07515872, a Phase 2 study, has not yet begun recruiting, sponsored by ZetrOZ.
- NOT YET RECRUITING
- Registry status
- Phase 2
- Development phase
- 240 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the ability of long-duration high-frequency continuous-wave therapeutic ultrasound to alleviate knee Osteoarthritis pain over an 12-week period. The primary objective of this study is to evaluate the analgesic effect of ultrasound treatment in subjects suffering from knee Osteoarthritis pain. Secondary objectives are to assess the ability of ultrasound treatment to improve joint function.
Primary Outcome
Change in the self-described pain units on a scale by patient at baseline and post-treatment
Interventions
- DEVICE Sustained Acoustic Device with 2.5% Diclofenac Patch
- DEVICE Sustained Acoustic Device with 0% Diclofenac Patch
- DRUG Intra articular injection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 240 participants |
| Start Date | 2026-05-01 |
| Est. Completion | 2028-05-31 |
| Phase | Phase 2 |
What is known before NCT07515872 opens enrollment
NCT07515872 is an interventional study that assigns participants to a tested intervention. The registered 240 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (80% higher).
The record links to 0 conditions, and to 3 interventions - of which Sustained Acoustic Device with 2.5% Diclofenac Patch is the first listed.
NCT07515872 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07515872 about?
NCT07515872 is a clinical study titled "Long Duration High Frequency Ultrasound for the Treatment of Osteoarthritis". The purpose of this study is to assess the ability of long-duration high-frequency continuous-wave therapeutic ultrasound to alleviate knee Osteoarthritis pain over an 12-week period. The primary objective of this study is to evaluate the analgesic effect of ultrasound treatment in subjects sufferin...
What is the current status of trial NCT07515872?
This trial is currently not yet recruiting. It is a Phase 2 study. The enrollment target is 240 participants. The study started on 2026-05-01. Estimated completion is 2028-05-31.
What interventions are being tested in trial NCT07515872?
The interventions under investigation include: Sustained Acoustic Device with 2.5% Diclofenac Patch (DEVICE), Sustained Acoustic Device with 0% Diclofenac Patch (DEVICE), Intra articular injection (DRUG).
Who is sponsoring clinical trial NCT07515872?
This trial is sponsored by ZetrOZ, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07515872's enrollment target sits among peer trials
240 239th of 2000 higher than 1,746 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02855554 · 240 participants · NA
Quantitative Cardiac Parametric Mapping
- NCT03230565 · 240 participants · Phase 4
Continuous Infusions vs Scheduled Bolus Infusions
- NCT03399929 · 240 participants
Traumatic Brain Injury and Stroke Long Term Outcome
- NCT03583710 · 240 participants · Phase 3
Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With Stage I-III Adrenocortical Cancer With High Risk of Recurrence
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI